Anthera Pharmaceuticals Inc. buy melinda
Start price
16.11.17
/
50%
€2.08
Target price
20.12.17
€4.51
Performance (%)
-34.92%
End price
20.12.17
€1.35
Summary
This prediction ended on 20.12.17 with a price of €1.35. The BUY prediction by melinda for Anthera Pharmaceuticals Inc. performed very badly with a performance of -34.92%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Anthera Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 1.280% | 1.027% | 11.234% | 16.273% |
| iShares Nasdaq 100 | -2.457% | -4.650% | 23.181% | 39.418% |
| iShares Nikkei 225® | -2.006% | -2.091% | 6.745% | 6.545% |
| iShares S&P 500 | -0.662% | -1.246% | 22.521% | 40.218% |
Comments by melinda for this prediction
In the thread Anthera Pharmaceuticals Inc. diskutieren
Biotechnologie und medizinische SecteurRecherche
Anthera Pharmaceuticals, Inc. ist ein biopharmazeutisches Unternehmen, wir qui Scharfstellung Entwicklung und Vermarktung von Produkten schwere und lebensbedrohlichen Krankheiten zu behandeln, einschließlich Lupus erythematodes mit Glomerulonephritis, IgA-Nephropathie und exokrinen Pankreasinsuffizienz aufgrund zystische fibrosis.I
(Vom Mitglied beendet)
Stopped prediction by melinda for Anthera Pharmaceuticals Inc.
Anthera Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.16
22.02.18
22.02.18
€4.51
11.09.18
11.09.18
-95.08%
11.09.18
11.09.18
Anthera Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.21
11.08.17
11.08.17
€1.80
13.11.17
13.11.17
41.88%
13.11.17
13.11.17
Anthera Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.34
11.08.17
11.08.17
€2.00
13.11.17
13.11.17
41.88%
13.11.17
13.11.17
Anthera Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€240.77
08.10.10
08.10.10
€281.60
11.04.11
11.04.11
23.90%
11.04.11
11.04.11